Impurity Profiling of a New Drug Entity
Experimental Insights
(Sprache: Englisch)
Impurity profiling and drug degradation pathways are essentials features for regulatory acceptance of any new drug entity. Despite of technological advancements in pharmaceutical analysis, structural elucidation of drug molecules, impurities produced during...
Leider schon ausverkauft
versandkostenfrei
Buch
35.90 €
Produktdetails
Produktinformationen zu „Impurity Profiling of a New Drug Entity “
Klappentext zu „Impurity Profiling of a New Drug Entity “
Impurity profiling and drug degradation pathways are essentials features for regulatory acceptance of any new drug entity. Despite of technological advancements in pharmaceutical analysis, structural elucidation of drug molecules, impurities produced during formulation remains challenging tasks for researchers. Unique chemical behavior, complex properties and interactions of different functional groups involved in active pharmaceutical ingredients along with different chemical environments with excipients and storage condition further complicate the issues. Furthermore isolation and characterization of impurities with special references to toxic metabolites is essential for acceptance of new drug molecules by regulatory agencies. Recently discovered and patented nitrate esters of paracetamol having improved analgesic and anti-inflammatory activities then parent drug and less hepatotoxicity in overdose is selected as model drug entity. This book is an attempt to provide experimental insights into the chemical, analytical and establishment of drug degradation pathways in forced conditions in lucid manner for easy understanding to meet future expectations of scientific fraternities.
Bibliographische Angaben
- Autoren: Neeraj Mishra , Ashish Baldi , Ravindra K. Rawal
- 2014, 80 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3846580120
- ISBN-13: 9783846580127
Sprache:
Englisch
Kommentar zu "Impurity Profiling of a New Drug Entity"
0 Gebrauchte Artikel zu „Impurity Profiling of a New Drug Entity“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Impurity Profiling of a New Drug Entity".
Kommentar verfassen